Show Summary Details
Page of

Percutaneous coronary intervention versus coronary artery bypass graft surgery 

Percutaneous coronary intervention versus coronary artery bypass graft surgery
Percutaneous coronary intervention versus coronary artery bypass graft surgery

Dr Richard Varcoe

and Dr Robert Henderson

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 July 2021

Obstructive coronary artery disease causing symptomatic myocardial ischaemia can be treated with anti-anginal medication or by myocardial revascularization, with either coronary artery bypass graft (CABG) surgery or percutaneous coronary intervention (PCI). Coronary artery bypass graft surgery began in the 1960s and rapidly became a routine treatment for patients with symptomatic coronary artery disease. Long-term clinical outcomes have improved with advances in surgical technique, particularly the use of internal mammary artery grafts.

Percutaneous coronary intervention was first performed in 1977 and was initially considered appropriate only in patients with an isolated proximal coronary artery stenosis. Technological advances, particularly the introduction of bare metal then drug eluting stents, together with developments in adjunctive pharmacology have improved clinical outcomes and expanded the indications for PCI to the treatment of more complex lesions and patient subsets, including those with multi-vessel and left main stem disease.

For some patients with multi-vessel coronary artery disease (CAD) both methods of myocardial revascularization may be technically feasible, but the optimal treatment strategy is uncertain. A number of randomized controlled trials have compared initial treatment strategies of CABG and PCI in patients who were considered to be clinically and angiographically suitable for either procedure and in whom there is equipoise about the most appropriate method of myocardial revascularization. These trials fall into several distinct eras as PCI technology has developed from balloon angioplasty, to bare metal, and then drug eluting stents. This chapter reviews the landmark trials from each of these three eras.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.